HEADER TRANSFERASE 21-OCT-16 5TPX TITLE BROMODOMAIN FROM PLASMODIUM FACIPARUM GCN5, COMPLEXED WITH COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE ACETYLTRANSFERASE GCN5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BROMODOMAIN (UNP RESIDUES 1356-1460); COMPND 5 EC: 2.3.1.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM (ISOLATE 3D7); SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: ISOLATE 3D7; SOURCE 5 GENE: PF3D7_0823300; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3)-PRARE2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15-MHL KEYWDS BROMODOMAIN, TRANSFERASE, STRUCTURAL GENOMICS CONSORTIUM (SGC) EXPDTA X-RAY DIFFRACTION AUTHOR Y.H.LIN,C.F.D.HOU,M.MOUSTAKIM,D.J.DIXON,P.LOPPNAU,W.TEMPEL,C.BOUNTRA, AUTHOR 2 A.M.EDWARDS,C.H.ARROWSMITH,R.HUI,P.E.BRENNAN,J.R.WALKER,STRUCTURAL AUTHOR 3 GENOMICS CONSORTIUM (SGC) REVDAT 5 04-OCT-23 5TPX 1 REMARK REVDAT 4 24-JAN-18 5TPX 1 AUTHOR REVDAT 3 22-NOV-17 5TPX 1 REMARK REVDAT 2 18-JAN-17 5TPX 1 JRNL REVDAT 1 04-JAN-17 5TPX 0 JRNL AUTH M.MOUSTAKIM,P.G.CLARK,L.TRULLI,A.L.FUENTES DE ARRIBA, JRNL AUTH 2 M.T.EHEBAUER,A.CHAIKUAD,E.J.MURPHY,J.MENDEZ-JOHNSON, JRNL AUTH 3 D.DANIELS,C.D.HOU,Y.H.LIN,J.R.WALKER,R.HUI,H.YANG,L.DORRELL, JRNL AUTH 4 C.M.ROGERS,O.P.MONTEIRO,O.FEDOROV,K.V.HUBER,S.KNAPP,J.HEER, JRNL AUTH 5 D.J.DIXON,P.E.BRENNAN JRNL TITL DISCOVERY OF A PCAF BROMODOMAIN CHEMICAL PROBE. JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 56 827 2017 JRNL REFN ESSN 1521-3773 JRNL PMID 27966810 JRNL DOI 10.1002/ANIE.201610816 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 8368 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.660 REMARK 3 FREE R VALUE TEST SET COUNT : 390 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.95 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2294 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2188 REMARK 3 BIN R VALUE (WORKING SET) : 0.1820 REMARK 3 BIN FREE R VALUE : 0.2570 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.62 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 106 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 870 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 66 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.07 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.27450 REMARK 3 B22 (A**2) : 6.27450 REMARK 3 B33 (A**2) : -12.54890 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.206 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.180 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.396 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.173 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1806 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3250 ; 3.800 ; HARMONIC REMARK 3 TORSION ANGLES : 392 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 23 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 280 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1806 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 120 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2027 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.67 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.70 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 23.6336 84.9790 57.9396 REMARK 3 T TENSOR REMARK 3 T11: -0.1830 T22: -0.2053 REMARK 3 T33: -0.0498 T12: 0.0118 REMARK 3 T13: 0.0204 T23: -0.0153 REMARK 3 L TENSOR REMARK 3 L11: 2.5974 L22: 1.9328 REMARK 3 L33: 1.8437 L12: 0.0600 REMARK 3 L13: -0.0608 L23: -0.2513 REMARK 3 S TENSOR REMARK 3 S11: -0.0098 S12: -0.2411 S13: -0.0128 REMARK 3 S21: 0.2183 S22: -0.0120 S23: 0.1618 REMARK 3 S31: -0.0784 S32: -0.0147 S33: 0.0219 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TPX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224617. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98011 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8411 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 37.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.80 REMARK 200 R MERGE FOR SHELL (I) : 0.72500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4QNS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PROTEIN WAS CRYSTALLIZED AT 293 K REMARK 280 IN 0.1M CACL2, 30% PEG 8K, 0.2M NH4SO4 WITH 2MM COMPOUND USING REMARK 280 THE SITTING DROP METHOD., PH 7.5, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 37.50000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 37.50000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.50000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 37.50000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.50000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A1502 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1637 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1338 REMARK 465 HIS A 1339 REMARK 465 HIS A 1340 REMARK 465 HIS A 1341 REMARK 465 HIS A 1342 REMARK 465 HIS A 1343 REMARK 465 HIS A 1344 REMARK 465 SER A 1345 REMARK 465 SER A 1346 REMARK 465 GLY A 1347 REMARK 465 ARG A 1348 REMARK 465 GLU A 1349 REMARK 465 ASN A 1350 REMARK 465 LEU A 1351 REMARK 465 TYR A 1352 REMARK 465 PHE A 1353 REMARK 465 GLN A 1354 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1357 CG CD CE NZ REMARK 470 GLN A1360 CD OE1 NE2 REMARK 470 LYS A1362 NZ REMARK 470 GLN A1376 CG CD OE1 NE2 REMARK 470 LYS A1398 NZ REMARK 470 LEU A1404 CD1 REMARK 470 LYS A1416 CE NZ REMARK 470 GLU A1419 CG CD OE1 OE2 REMARK 470 LYS A1444 NZ REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7H7 A 1505 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QNS RELATED DB: PDB REMARK 900 4QNS CONTAINS THE SAME PROTEIN COMPLEXED WITH BROMOSPORIN. DBREF 5TPX A 1356 1460 UNP Q8IB67 Q8IB67_PLAF7 1356 1460 SEQADV 5TPX MET A 1338 UNP Q8IB67 INITIATING METHIONINE SEQADV 5TPX HIS A 1339 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX HIS A 1340 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX HIS A 1341 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX HIS A 1342 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX HIS A 1343 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX HIS A 1344 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX SER A 1345 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX SER A 1346 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX GLY A 1347 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX ARG A 1348 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX GLU A 1349 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX ASN A 1350 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX LEU A 1351 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX TYR A 1352 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX PHE A 1353 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX GLN A 1354 UNP Q8IB67 EXPRESSION TAG SEQADV 5TPX GLY A 1355 UNP Q8IB67 EXPRESSION TAG SEQRES 1 A 123 MET HIS HIS HIS HIS HIS HIS SER SER GLY ARG GLU ASN SEQRES 2 A 123 LEU TYR PHE GLN GLY HIS LYS GLU VAL GLN LEU LYS ASP SEQRES 3 A 123 GLN ILE LEU GLY VAL LEU ASP TYR LEU GLU LYS GLN GLN SEQRES 4 A 123 SER ALA TRP PRO PHE LEU LYS PRO VAL SER LEU SER GLU SEQRES 5 A 123 ALA PRO ASP TYR TYR ASP ILE ILE LYS GLU PRO THR ASP SEQRES 6 A 123 ILE LEU THR MET ARG ARG LYS ALA ARG HIS GLY ASP TYR SEQRES 7 A 123 LYS THR LYS GLU ASP PHE GLY ILE GLU LEU LYS ARG MET SEQRES 8 A 123 PHE ASP ASN CYS ARG LEU TYR ASN ALA PRO THR THR ILE SEQRES 9 A 123 TYR PHE LYS TYR ALA ASN GLU LEU GLN THR LEU ILE TRP SEQRES 10 A 123 PRO LYS TYR GLU ALA ILE HET CL A1501 1 HET SO4 A1502 5 HET SO4 A1503 5 HET SO4 A1504 5 HET 7H7 A1505 27 HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETNAM 7H7 (1S,2S)-N~1~,N~1~-DIMETHYL-N~2~-(3-METHYL[1,2, HETNAM 2 7H7 4]TRIAZOLO[3,4-A]PHTHALAZIN-6-YL)-1-PHENYLPROPANE-1,2- HETNAM 3 7H7 DIAMINE FORMUL 2 CL CL 1- FORMUL 3 SO4 3(O4 S 2-) FORMUL 6 7H7 C21 H24 N6 FORMUL 7 HOH *66(H2 O) HELIX 1 AA1 GLY A 1355 LYS A 1374 1 20 HELIX 2 AA2 GLN A 1375 LYS A 1383 5 9 HELIX 3 AA3 ASP A 1392 ILE A 1397 1 6 HELIX 4 AA4 ASP A 1402 HIS A 1412 1 11 HELIX 5 AA5 THR A 1417 ASN A 1436 1 20 HELIX 6 AA6 THR A 1440 ALA A 1459 1 20 SITE 1 AC1 1 LYS A1383 SITE 1 AC2 3 ARG A1407 ARG A1411 HIS A1412 SITE 1 AC3 3 TYR A1457 HOH A1621 HOH A1653 SITE 1 AC4 10 TRP A1379 PRO A1380 LYS A1383 PRO A1384 SITE 2 AC4 10 VAL A1385 GLU A1389 TYR A1394 ASN A1436 SITE 3 AC4 10 TYR A1442 HOH A1607 CRYST1 75.000 75.000 49.620 90.00 90.00 90.00 P 4 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013333 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013333 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020153 0.00000